Recruiting OBSERVATIONAL NCT05991219

Screening and Secondary Prevention Rheumatic Heart Disease Study (S2-RHD)

Screening and Secondary Prevention Rheumatic Heart Disease

Sponsor: National Institute of Cardiovascular Diseases, Pakistan

Updated 3 times since 2023 Last updated: Aug 12, 2023 Started: Sep 26, 2022 Primary completion: Dec 31, 2028 Completion: Dec 31, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Rheumatic Heart Disease and is currently actively recruiting participants. National Institute of Cardiovascular Diseases, Pakistan leads this study, which shows 3 recorded versions since 2022 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Recruiting
Jul 2024 — Sep 2024 [monthly]

Recruiting
Sep 2023 — Jul 2024 [monthly]

Recruiting

First recorded

Sep 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute of Cardiovascular Diseases, Pakistan

Data source: National Institute of Cardiovascular Diseases, Pakistan

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karachi, Pakistan